Results 21 to 30 of about 4,783,149 (369)

Increased risk of high-grade prostate cancer among testicular cancer survivors.

open access: yesPLoS ONE, 2022
IntroductionTesticular cancer survivors (TCS) have an increased risk of additional cancers, including prostate cancer. Our understanding of the natural history of prostate cancer in testicular cancer survivors is very limited due to its rare incidence ...
Hong Zhang   +6 more
doaj   +2 more sources

Cisplatin-based chemotherapy of testicular cancer - Two decades after a major breakthrough [PDF]

open access: yes, 2000
Two decades ago the introduction of cisplatin-based combination chemotherapy has dramatically improved the prognosis of patients with metastatic testicular cancer, At present 3 cycles of cisplatin, etoposide and bleomycin are considered as standard ...
Gerl, Arthur
core   +1 more source

Non-Coding microRNAs as Novel Potential Tumor Markers in Testicular Cancer

open access: yesCancers, 2020
Testicular cancer is an important disease with increasing incidence and a high burden of morbidity and mortality in young men worldwide. Histological examination of the testicular tissue after orchiectomy plays an important role alongside patient history,
Manuel Regouc   +4 more
semanticscholar   +1 more source

Oncological outcomes of testicular cancer patients: 10 years of experiences resulting from a single university-based hospital

open access: yesForum of Clinical Oncology, 2022
To explore clinical and pathological characteristics of testicular cancer and also identify factors associated with its oncological outcomes. Testicular cancer has a very good prognosis.
Bejrananda Tanan   +3 more
doaj   +1 more source

The Testicular Cancer Consortium (TECAC): Filling Knowledge Gaps in the Genetic Etiology of Testicular Germ Cell Tumors. [PDF]

open access: yesAndrology
ABSTRACT Background The Testicular Cancer Consortium (TECAC) was established in 2012 and is comprised of researchers from over 25 centers in Europe and North America. TECAC's overarching goal is to investigate the genetic susceptibility of testicular germ cell tumors (TGCT) to better understand their biology, impact prevention strategies, and inform ...
Kanetsky PA   +28 more
europepmc   +2 more sources

Androgen receptor polymorphisms and testicular cancer risk [PDF]

open access: yes, 2015
Testicular cancer (TC) is currently the most common malignant solid tumour in Caucasian males aged 15-39 years. Epidemiological evidence suggests that its onset may be due to an imbalance in the action of steroidal sex hormones and their receptors.
CARLINI, TANIA   +9 more
core   +1 more source

Fertility considerations in men with testicular cancer.

open access: yesTranslational Andrology and Urology, 2020
The modern approach to cancer management has evolved into a multidisciplinary initiative focused not only on cancer specific and overall survival, but also patient quality of life and survivorship.
N. Parekh, Scott D. Lundy, S. Vij
semanticscholar   +1 more source

Association between testicular microlithiasis, testicular cancer, cryptorchidism and history of ascending testis

open access: yesInternational Brazilian Journal of Urology, 2006
OBJECTIVE: To prospectively determine the prevalence of testicular microlithiasis in symptomatic patients who were referred for scrotal ultrasound examination and to evaluate the possible association of testicular microlithiasis with testicular cancer ...
Stamatiou Konstantinos   +7 more
doaj   +1 more source

Testicular cancer in two brothers of a quadruplet: a case report and a review of literature

open access: yesActa Medica Lituanica, 2017
Introduction. Testicular cancer and a multiple birth are both rare events, and the risk of testicular cancer is increased in twins. In Lithuania, only five quadruplets have been recorded since the middle of the 20th century.
Agnė Ulytė   +4 more
doaj   +1 more source

Cumulative Burden of Morbidity Among Testicular Cancer Survivors After Standard Cisplatin-Based Chemotherapy: A Multi-Institutional Study [PDF]

open access: yes, 2018
Purpose In this multicenter study, we evaluated the cumulative burden of morbidity (CBM) among > 1,200 testicular cancer survivors and applied factor analysis to determine the co-occurrence of adverse health outcomes (AHOs).
AnnaLynn M. Williams   +20 more
core   +1 more source

Home - About - Disclaimer - Privacy